These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11928907)

  • 1. Reduction of instability-induced bone resorption using bisphosphonates: high doses are needed in rats.
    Astrand J; Aspenberg P
    Acta Orthop Scand; 2002 Jan; 73(1):24-30. PubMed ID: 11928907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rat model for testing pharmacologic treatments of pressure-related bone loss.
    Astrand J; Skripitz R; Skoglund B; Aspenberg P
    Clin Orthop Relat Res; 2003 Apr; (409):296-305. PubMed ID: 12671515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical, single dose bisphosphonate treatment reduced bone resorption in a rat model for prosthetic loosening.
    Astrand J; Aspenberg P
    J Orthop Res; 2004 Mar; 22(2):244-9. PubMed ID: 15013081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone allografts pretreated with a bisphosphonate are not resorbed.
    Aspenberg P; Astrand J
    Acta Orthop Scand; 2002 Jan; 73(1):20-3. PubMed ID: 11928906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening.
    Aspenberg P; Agholme F; Magnusson P; Fahlgren A
    Bone; 2011 Feb; 48(2):225-30. PubMed ID: 20858557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of alendronate on endosseous implant integration: an in vivo study in rabbits.
    Chacon GE; Stine EA; Larsen PE; Beck FM; McGlumphy EA
    J Oral Maxillofac Surg; 2006 Jul; 64(7):1005-9. PubMed ID: 16781331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alendronate increases skeletal mass of growing rats during unloading by inhibiting resorption of calcified cartilage.
    Bikle DD; Morey-Holton ER; Doty SB; Currier PA; Tanner SJ; Halloran BP
    J Bone Miner Res; 1994 Nov; 9(11):1777-87. PubMed ID: 7863829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of inflammatory and bone-resorption-inhibitory effects of alendronate by etidronate.
    Funayama H; Ohsako M; Monma Y; Mayanagi H; Sugawara S; Endo Y
    Calcif Tissue Int; 2005 Jun; 76(6):448-57. PubMed ID: 15895282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bisphosphonate pamidronate on the surface of titanium stimulates bone formation around tibial implants in rats.
    Kajiwara H; Yamaza T; Yoshinari M; Goto T; Iyama S; Atsuta I; Kido MA; Tanaka T
    Biomaterials; 2005 Feb; 26(6):581-7. PubMed ID: 15282136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective implant osseointegration under protein undernutrition: prevention by PTH or pamidronate.
    Dayer R; Badoud I; Rizzoli R; Ammann P
    J Bone Miner Res; 2007 Oct; 22(10):1526-33. PubMed ID: 17563238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of PTH-stimulated osteoclastic resorption by bisphosphonates in fetal mouse bone explants.
    van der Pluijm G; Löwik CW; de Groot H; Alblas MJ; van der Wee-Pals LJ; Bijvoet OL; Papapoulos SE
    J Bone Miner Res; 1991 Nov; 6(11):1203-10. PubMed ID: 1839590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy.
    Sato M; Grasser W
    J Bone Miner Res; 1990 Jan; 5(1):31-40. PubMed ID: 2106763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preclinical toxicology of bisphosphonates].
    Mondelo N; Peluffo VA; Parma MD; Cointry GR; Capozza RF; Ferretti JL; Piccinni E; Montuori E
    Medicina (B Aires); 1997; 57 Suppl 1():93-100. PubMed ID: 9567361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.
    Sato M; Grasser W; Endo N; Akins R; Simmons H; Thompson DD; Golub E; Rodan GA
    J Clin Invest; 1991 Dec; 88(6):2095-105. PubMed ID: 1661297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental results of combining bisphosphonates with allograft in a rat model.
    Agholme F; Aspenberg P
    J Bone Joint Surg Br; 2009 May; 91(5):670-5. PubMed ID: 19407306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periarticular bone alterations in chronic antigen-induced arthritis: free and liposome-encapsulated clodronate prevent loss of bone mass in the secondary spongiosa.
    Oelzner P; Bräuer R; Henzgen S; Thoss K; Wünsche B; Hersmann G; Abendroth K; Kinne RW
    Clin Immunol; 1999 Jan; 90(1):79-88. PubMed ID: 9884355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alendronate did not inhibit instability-induced bone resorption. A study in rats.
    Astrand J; Aspenberg P
    Acta Orthop Scand; 1999 Feb; 70(1):67-70. PubMed ID: 10191752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiresorptive dose-response relationships across three generations of bisphosphonates.
    Sietsema WK; Ebetino FH; Salvagno AM; Bevan JA
    Drugs Exp Clin Res; 1989; 15(9):389-96. PubMed ID: 2630251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone resorption in orthotopic and heterotopic bone of dichloromethylene bisphosphonate-treated rats.
    Nilsson OS; Bauer HC; Brosjö O; Törnkvist H
    J Orthop Res; 1990 Mar; 8(2):213-9. PubMed ID: 2137534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Improved osseointegration and periprosthetic bone volume around cementless metal implants under bisphosphonate treatment].
    Eberhardt C; Raussen W; Thiemann S; Schwarz M; Bauss F; Kurth AA
    Z Orthop Ihre Grenzgeb; 2005; 143(6):645-51. PubMed ID: 16380896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.